

<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
	<title>MHRA news feed</title>
	<link>http://www.mhra.gov.uk/home/idcplg?IdcService=SS_GET_PAGE&amp;nodeId=100806</link>
 

<item>
<title>Non executive directors sought for the Medicines and Healthcare products Regulatory Agency</title>
<pubDate>Fri, 18 May 2012 11:51:00 UTC</pubDate>
<link>http://www.mhra.gov.uk/NewsCentre/CON152721 </link>
	 <description><![CDATA[The Secretary of State for Health is seeking to appoint up to four non executive directors (NEDs) to the MHRA.<br/> ]]></description>
	 </item>
 

<item>
<title>News: Lorem ipsum dolor sit amet...</title>
<pubDate>Fri, 11 May 2012 16:43:00 UTC</pubDate>
<link>http://www.mhra.gov.uk/NewsCentre/CON152657 </link>
	 <description><![CDATA[Summary<br/> ]]></description>
	 </item>
 

<item>
<title>Precautionary recall of Viaspan</title>
<pubDate>Thu, 10 May 2012 13:16:00 UTC</pubDate>
<link>http://www.mhra.gov.uk/NewsCentre/CON146896 </link>
	 <description><![CDATA[A precautionary recall of all batches of Viaspan, a solution used in organ transplant operations, manufactured since 4 July 2011 has been proposed by the manufacturer Bristol-Myers Squibb (BMS).<br/> ]]></description>
	 </item>
 

<item>
<title>Reduction in deaths involving co-proxamol after withdrawal from UK market</title>
<pubDate>Wed, 09 May 2012 16:33:00 UTC</pubDate>
<link>http://www.mhra.gov.uk/NewsCentre/CON152637 </link>
	 <description><![CDATA[A study published in the journal ‘Public Library of Science (PLoS) Medicine’ has found that during the six years following the withdrawal of the analgesic co-proxamol in the UK in 2005, there was a major reduction in poisoning deaths involving this medicine, without apparent significant increase in deaths involving other analgesics.<br/> ]]></description>
	 </item>
 

<item>
<title>Information about Macrolane injectable dermal filler</title>
<pubDate>Tue, 08 May 2012 15:40:00 UTC</pubDate>
<link>http://www.mhra.gov.uk/NewsCentre/CON149797 </link>
	 <description><![CDATA[The MHRA is aware that the manufacturer Q-Med has decided to discontinue the dermal filler Macrolane for breast augmentation only.<br/> ]]></description>
	 </item>
 

<item>
<title>Sports and body building supplements</title>
<pubDate>Thu, 03 May 2012 11:17:00 UTC</pubDate>
<link>http://www.mhra.gov.uk/NewsCentre/CON152585 </link>
	 <description><![CDATA[Products related to sports and body building frequently come to the MHRA’s attention and are often found to be unacceptable for sale in the UK even though they may be legitimate products in other countries.<br/> ]]></description>
	 </item>
 

<item>
<title>MHRA responds to research paper published in the Lancet</title>
<pubDate>Fri, 13 Apr 2012 13:45:00 UTC</pubDate>
<link>http://www.mhra.gov.uk/NewsCentre/CON146669 </link>
	 <description><![CDATA[The MHRA has responded to the research paper ‘Failure rates of stemmed metal-on-metal hip replacements’ as published in the Lancet (12 March 2012).<br/> ]]></description>
	 </item>
 

<item>
<title>MHRA letter in response to article in the Sunday Times</title>
<pubDate>Fri, 13 Apr 2012 13:45:00 UTC</pubDate>
<link>http://www.mhra.gov.uk/NewsCentre/CON146674 </link>
	 <description><![CDATA[The MHRA has written a letter to the editor of the Sunday Times in response to an article published on 11 March 2012.<br/> ]]></description>
	 </item>
 

<item>
<title>MHRA issues new information for women who had PIP silicone gel breast implants before January 2001</title>
<pubDate>Thu, 15 Mar 2012 16:07:00 UTC</pubDate>
<link>http://www.mhra.gov.uk/NewsCentre/CON146714 </link>
	 <description><![CDATA[The MHRA today issued new information to surgeons and doctors that women in the UK who received Poly Implant Prosthese (PIP) silicone gel breast implants before 1 January 2001 should now be managed in the same way as those who had the implants after that date.<br/> ]]></description>
	 </item>
 

<item>
<title>Learning package on opioids launched</title>
<pubDate>Thu, 15 Mar 2012 15:15:00 UTC</pubDate>
<link>http://www.mhra.gov.uk/NewsCentre/CON146684 </link>
	 <description><![CDATA[We have just launched a learning module on opioids for clinical practitioners. This self-directed learning package outlines the key risks of this important class of medicines. Self-assessment questions, together with full feedback, complement the learning material. Interspersed in the content, clinicians will find ‘activities’ to help consolidate the learning.<br/> ]]></description>
	 </item>
 

<item>
<title>MHRA letter in response to article in the BMJ</title>
<pubDate>Thu, 15 Mar 2012 09:08:00 UTC</pubDate>
<link>http://www.mhra.gov.uk/NewsCentre/CON146692 </link>
	 <description><![CDATA[The MHRA has written a letter to the editor of the BMJ in response to their article '‘Hip implants: how safe is metal on metal?’<br/> ]]></description>
	 </item>
 

<item>
<title>MHRA letter in response to article in the Guardian</title>
<pubDate>Wed, 14 Mar 2012 16:38:00 UTC</pubDate>
<link>http://www.mhra.gov.uk/NewsCentre/CON146688 </link>
	 <description><![CDATA[The MHRA has written a letter to the editor of the Guardian in response to an article published on 13 March 2012.<br/> ]]></description>
	 </item>
 

<item>
<title>MHRA letter to the editor of the BMJ</title>
<pubDate>Wed, 14 Mar 2012 16:27:00 UTC</pubDate>
<link>http://www.mhra.gov.uk/home/groups/comms-po/documents/news/con146690.pdf</link>
	 <description><![CDATA[The MHRA has written a letter to the editor of the BMJ in response to their article '‘Hip implants: how safe is metal on metal?’<br/> ]]></description>
	 </item>
 

<item>
<title>Letter to the editor in response to a BMJ article about the Science Media Centre Briefing</title>
<pubDate>Tue, 13 Mar 2012 18:31:00 UTC</pubDate>
<link>http://www.mhra.gov.uk/NewsCentre/CON146483 </link>
	 <description><![CDATA[The MHRA has written a letter to the editor of the BMJ in response to their article about the Science Media Centre Briefing published on 17 February 2012.<br/> ]]></description>
	 </item>
 

<item>
<title>MHRA response to article in the Daily Star Sunday</title>
<pubDate>Tue, 13 Mar 2012 17:45:00 UTC</pubDate>
<link>http://www.mhra.gov.uk/NewsCentre/CON143715 </link>
	 <description><![CDATA[MHRA has written a letter to the editor of the Daily Star Sunday in response to their article on 19 February 2012.<br/> ]]></description>
	 </item>
 

<item>
<title>MHRA sits on project team for newly-formed Health Research Authority (HRA)</title>
<pubDate>Mon, 12 Mar 2012 11:16:00 UTC</pubDate>
<link>http://www.mhra.gov.uk/NewsCentre/CON146596 </link>
	 <description><![CDATA[The Health Research Authority (HRA) is a newly formed NHS organisation established on 01 December 2011 as a Special Health Authority.<br/> ]]></description>
	 </item>
 

<item>
<title>MHRA letter in response to article in the Independent</title>
<pubDate>Mon, 05 Mar 2012 15:44:00 UTC</pubDate>
<link>http://www.mhra.gov.uk/NewsCentre/CON146507 </link>
	 <description><![CDATA[The MHRA has written a letter to the editor of the Independent in response to their article '‘The regulator needs to recover its grip, fast’ (29 February 2012)<br/> ]]></description>
	 </item>
 

<item>
<title>MHRA letter in response to article in the Independent</title>
<pubDate>Mon, 05 Mar 2012 15:33:00 UTC</pubDate>
<link>http://www.mhra.gov.uk/home/groups/comms-po/documents/news/con146508.pdf</link>
	 <description><![CDATA[The MHRA has written a letter to the editor of the Independent in response to their article '‘The regulator needs to recover its grip, fast’ (29 February 2012)<br/> ]]></description>
	 </item>
 

<item>
<title>Video highlights of the MHRA Annual Lecture now available on YouTube</title>
<pubDate>Mon, 05 Mar 2012 14:50:00 UTC</pubDate>
<link>http://www.mhra.gov.uk/NewsCentre/CON146492 </link>
	 <description><![CDATA[Video highlights of the MHRA Annual Lecture are now available on YouTube.Professor David Spiegelhalter gave the MHRA’s 7th Annual Lecture “Conveying the benefits and harms of treatments” on Wednesday 18 January 2012.<br/> ]]></description>
	 </item>
 

<item>
<title>Conveying the benefits and harms of treatments - slides from Dr Spiegelhalter</title>
<pubDate>Mon, 05 Mar 2012 14:48:00 UTC</pubDate>
<link>http://www.mhra.gov.uk/home/groups/comms-po/documents/news/con146506.pdf</link>
	 <description><![CDATA[Video highlights of the MHRA Annual Lecture are now available on YouTube.Professor David Spiegelhalter gave the MHRA’s 7th Annual Lecture “Conveying the benefits and harms of treatments” on Wednesday 18 January 2012.<br/> ]]></description>
	 </item>
 

<item>
<title>Continuing professional education for health professionals</title>
<pubDate>Mon, 13 Feb 2012 12:28:00 UTC</pubDate>
<link>http://www.mhra.gov.uk/NewsCentre/CON143604 </link>
	 <description><![CDATA[We are pleased that the Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the United Kingdom has approved the MHRA learning modules on pharmacovigilance and selective serotonin reuptake inhibitors (SSRIs) for CPD credits.<br/> ]]></description>
	 </item>
 

<item>
<title>Report on PIP implants issued by the Scientific Committee on Emerging and Newly Identified Health Risks of the European Commission</title>
<pubDate>Mon, 06 Feb 2012 17:29:00 UTC</pubDate>
<link>http://www.mhra.gov.uk/NewsCentre/CON143575 </link>
	 <description><![CDATA[A report on PIP implants has been issued by the Scientific Committee on Emerging and Newly Identified Health Risks of the European Commission, which states that there is insufficient evidence to warrant a conclusion that women with PIP silicone breast implants have a greater risk to their health than women with breast implants from other manufacturers.<br/> ]]></description>
	 </item>
 

<item>
<title>MHRA letter in response to Financial Times article</title>
<pubDate>Thu, 02 Feb 2012 17:23:00 UTC</pubDate>
<link>http://www.mhra.gov.uk/NewsCentre/CON143543 </link>
	 <description><![CDATA[The MHRA has written a letter to the editor of the Financial Times in response to an article.<br/> ]]></description>
	 </item>
 

<item>
<title>MHRA statement on metal-on-metal hip implants</title>
<pubDate>Wed, 01 Feb 2012 12:59:00 UTC</pubDate>
<link>http://www.mhra.gov.uk/NewsCentre/CON140854 </link>
	 <description><![CDATA[Details of the current situation for metal-on-metal hip implants and a statement from an MHRA spokesperson.<br/> ]]></description>
	 </item>
 

<item>
<title>MHRA statement on polyurethane-coated breast implants</title>
<pubDate>Tue, 31 Jan 2012 12:48:00 UTC</pubDate>
<link>http://www.mhra.gov.uk/NewsCentre/CON140879 </link>
	 <description><![CDATA[Statement from an MHRA spokesperson on polyurethane-coated breast implants.<br/> ]]></description>
	 </item>
</channel>
</rss>
<!-- the HEAD element is required by SiteStudio
	<head><script language="JavaScript">
   var _U = "undefined";
   var g_HttpRelativeWebRoot = "/home/";
   var SSContributor = false;
   var SSForceContributor = false;
   var SSHideContributorUI = false;
   var ssUrlPrefix   = "/";
   var g_navNode_Path = new Array();
       g_navNode_Path[0] = '5';
       g_navNode_Path[1] = '338';
       g_navNode_Path[2] = '100806';
       g_navNode_Path[3] = '100843';
   var g_ssSourceNodeId = "100843";
   var g_ssSourceSiteId = "5";
   var g_strLanguageId = "en";
</script>
<script id="SSNavigationFunctionsScript" language="javascript" type="text/javascript" src="/home/websites/5/sitenavigationfunctions.js"></script>
<script id="SSNavigationScript" language="javascript" type="text/javascript" src="/home/websites/5/sitenavigation.js"></script>

	<script type="text/javascript" src="/home/resources/wcm/sitestudio/wcm.toggle.js"></script>
	<script type="text/javascript" src="/home/resources/sitestudio/ssajax/ssajax.js"></script>

	</head>
-->


